Figure 3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk

Lenka Stolarova,Petra Kleiblova,Petra Zemankova, Barbora Stastna,Marketa Janatova,Jana Soukupova,Maria Isabel Achatz,Christine Ambrosone,Paraskevi Apostolou,Banu K. Arun,Paul Auer,Mollie Barnard, Birgitte Bertelsen,Koichi Matsuda,Yoichiro Kamatani,Takayuki Morisaki,Akiko Nagai, Kaori Muto,Yoshinori Murakami,Yoichi Furukawa, Yuji Yamanashi,Yusuke Nakamura,Taisei Mushiroda,Yukihide Momozawa,Toshihiro Tanaka, Yozo Ohnishi,Michiaki Kubo, Shinichi Higashiue, Shuzo Kobayashi,Shiro Minami, Hiroki Yamaguhci, Hajime Arai,Ken Yamaji,Yasushi Okazaki,Satoshi Asai,Yasuo Takahashi,Tomoaki Fujioka,Wataru Obara,Seijiro Mori, Shigeo Murayama,Satoshi Nagayama,Yoshio Miki,Akihide Masumoto, Akira Yamada, Yasuko Nishizawa,Masahiko Higashiyama, Hiromu Kutsumi,Yukihiro Koretsune, Takashi Yoshiyama,Marinus J. Blok,Nicholas Boddicker,Joan Brunet,Elizabeth S. Burnside,Mariarosaria Calvello,Ian Campbell,Sock Hoai Chan,Fei Chen,Jian Bang Chiang,Anna Coppa,Laura Cortesi, Ana Crujeiras-González,Marianna Borecka, Marta Cerna,Milena Hovhannisyan, Sandra Jelinkova,Petr Nehasil,Lenka Foretova,Eva Machackova, Vera Krutilkova,Spiros Tavandzis, Leona Cerna, Stepan Chvojka, Monika Koudova, Alena Puchmajerova,Ondrej Havranek,Jan Novotny,Kamila Vesela,Michal Vocka, Lucie Hruskova, Renata Michalovska, Denisa Schwetzova, Zdenka Vlckova, Monika Cerna, Marketa Hejnalova, Nikol Jedlickova,Ivan Subrt, Tomas Zavoral, Marcela Kosarova, Gabriela Vacinova, Maria Janikova,Romana Kratochvilova, Vaclava Curtisova,Radek Vrtel, Ondrej Scheinost, Petra Duskova,Viktor Stranecky,Kim De Leeneer,Robin De Putter, Allison DePersia,Lisa Devereux, Susan Domchek, Anna Efremidis, Christoph Engel, Corinna Ernst, D. Gareth R. Evans, Lidia Feliubadaló, Florentia Fostira, Olivia Fuentes-Ríos, Encarna B. Gómez-García, Sara González, Christopher Haiman, Thomas van Overeem Hansen, Jan Hauke, James Hodge, Chunling Hu, Hongyan Huang, Nur Diana Binte Ishak, Yusuke Iwasaki, Irene Konstantopoulou, Peter Kraft, James Lacey, Conxi Lázaro, Na Li, Weng Khong Lim, Sara Lindstrom, Adriana Lori, Elana Martinez, Alexandra Martins,Koichi Matsuda, Giuseppe Matullo, Simone McInerny, Kyriaki Michailidou, Marco Montagna, Alvaro N.A. Monteiro, Luigi Mori, Katherine Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Janet E. Olson, Julie Palmer, Barbara Pasini, Alpa Patel, Maria Piane, Bruce Poppe, Paolo Radice, Alessandra Renieri, Nicoletta Resta, Marcy E. Richardson, Toon Rosseel, Kathryn J. Ruddy, Marta Santamariña, Elizabeth Santana Dos Santos, Lauren Teras, Amanda E. Toland, Amy Trentham-Dietz, Celine M. Vachon, Alexander E. Volk, Nana Weber-Lassalle, Jeffrey N. Weitzel, Lisa Wiesmuller, Stacey Winham, Siddhartha Yadav, Drakoulis Yannoukakos, Song Yao, Valentina Zampiga, Magnus Zethoven, Ze Wen Zhang, Tomas Zima, Amanda B. Spurdle, Ana Vega, Maria Rossing, Jesús Del Valle, Arcangela De Nicolo, Eric Hahnen, Kathleen B.M. Claes, Joanne Ngeow,Yukihide Momozawa,Paul A. James, Fergus J. Couch, Libor Macurek, Zdenek Kleibl

crossref(2023)

引用 0|浏览15
暂无评分
摘要

Kinase KAP1 and CHK2 assays (A). The bar graphs show results of kinase assays for 430 CHEK2 missense variants. In both assays, variants with normalized relative CHK2 activity (mean WT-activity = 1) exceeding that of the weakest signal of WT replicas (not shown) were categorized functionally WT-like, variants with normalized signal intensity lower than the strongest signal for any of kinase-dead/empty EGFP vector controls (in-frame exon 7 deletion–p.D265_H282del; not shown) were categorized as functionally impaired. Variants with normalized CHK2 activities between these ranges were categorized functionally intermediate (0.428–0.705 and 0.479–0.710 for KAP1 and CHK2 assay, respectively; indicated by red and yellow dashed lines). Scatterplot combines results from both assays showing 340 concordant (circles) and 90 discordant (crosses) variants. The nuclear-to-cytoplasmic ratio (B) bar graph (left) displays all missense variants and a set of protein-truncating CHEK2 variants (dark red bars at left, zoomed part of the graph). The missense variants, p.R521W and p.R521Q, with an aberrant localization are highlighted as bright-red bars; the arrows denote WT (green bar) and catalytically-dead in-frame p.D265_H282del variant (white bar). The highest and lowest mean nuclear/cytoplasmic ratio values from all WT replicates are indicated by green dashed lines. Of all missense variants analyzed by ScanR microscopy, only codon 521 alterations revealed aberrant intracellular localization with intense cytoplasmic positivity (right), reminiscent of mislocalization of the c.1100delC (p.T367fsX; size bar, 10 μm) variant. In comparison, the in-frame deletion p.D265_H282del revealed normal intranuclear accumulation, similar to WT. C, Scatter plots depicting correlations between assays performed in this study and previous analyses of CHEK2 VUS. Studies of Kleiblova et al. (17) and Boonen et al. (18) used phosphorylation of KAP1 as a functional readout whereas the study of Delimitsou et al. (25) used a yeast growth retardation assay. The dots are colored according to the results of the KAP1 assay in this study (red, impaired; yellow, intermediate; green, wild-type–like). Blue line represents linear regression, R, correlation coefficient; P, P value. The scatter plot does not show the p.Arg512Trp variant classified by Boonen et al. as intermediate with impaired nuclear localization in our localization assay.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要